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Background: Central venous catheters play an important role in patient care. Real-time ultrasound-guided subclavian
central venous (SCV) cannulation may reduce the incidence of complications and the time between skin penetration
and the aspiration of venous blood into the syringe. Ultrasonic diagnosis of catheter misplacement and pneumothorax
related to central venous catheterization is rapid and accurate. It is unclear, however, whether ultrasound real-time
guidance and examination can reduce procedure times and complication rates when compared with landmark
guidance and radiographic examination for SCV catheterization.
Methods/Design: The Subclavian Central Venous Catheters Guidance and Examination by UltraSound (SUBGEUS)
study is an investigator-initiated single center, randomized, controlled two-arm trial. Three hundred patients undergoing
SCV catheter placement will be randomized to ultrasound real-time guidance and examination or landmark guidance
and radiographic examination. The primary outcome is the time between the beginning of the procedure and control
of the catheter. Secondary outcomes include the times required for the six components of the total procedure, the
occurrence of complications (pneumothorax, hemothorax, or misplacement), failure of the technique and occurrence
of central venous catheter infections.
Discussion: The SUBGEUS trial is the first randomized controlled study to investigate whether ultrasound real-time
guidance and examination for SCV catheter placement reduces all procedure times and the rate of complications.
Trial registration: ClinicalTrials.gov Identifier: NCT01888094
Keywords: central venous catheter, subclavian vein, ultrasound guidance, pulmonary ultrasound, cardiac ultrasound,
contrast testBackground
Central venous catheters play an important role in patient
care, especially in the intensive care unit (ICU). However,
their use is associated with various complications, which
occur more frequently when catheters are placed through
routes involving the subclavian vein than through routes
involving the internal jugular and femoral veins [1,2].* Correspondence: sperbet@chu-clermontferrand.fr
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unless otherwise stated.Nevertheless, the subclavian vein route is associated with
lower rates of infection and thrombosis and remains
the route of choice in the ICU [3,4]. Real-time ultrasound-
guided central venous cannulation results in a lower
technical failure rate (overall and on first attempt), faster
access, and a reduction in mechanical complications,
although this has been validated mainly for the internal
jugular vein [5,6]. One study reported that complications
and failure rates of subclavian central venous (SCV)
catheterization were lower for real-time ultrasound-
assisted vein location [7]. However, the only temporal
parameter recorded was the time between penetrationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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inge; thus, the time required for the entire procedure
has never been evaluated. Ultrasonic diagnosis of cath-
eter misplacement and pneumothorax related to central
venous catheterization was reported to be a rapid and
accurate method that can be easily performed by ICU
physicians [8].
The Subclavian Central Venous Catheters Guidance and
Examination by UltraSound (SUBGEUS) study aims to
compare the complete time required for the procedure
and the rate of complications of a global ultrasound
method and a standard (landmark and radiographic)
method used in the routine cannulation of the sub-
clavian vein in patients requiring a central line.Methods/Design
Objectives and design
The SUBGEUS study is an investigator-initiated, single
center, randomized, controlled trial approved by the In-
stitutional Review Board of Clermont-Ferrand, France
(AU-1000, Eudra-CT 2012-A01188-35). Informed consent
is obtained from each participant. The SUBGEUS study is
conducted in accordance with the Declaration of Helsinki
and was registered on June 25, 2013, on http://clinical-
trials.gov/ as trial NCT01888094.CONSORT diagram
Figure 1 shows the CONSORT diagram of the SUBGEUS
trial.Study population
Investigators screen consecutive patients who are admitted
to the ICU and require a central venous line. Inclusion cri-
teria are requirement for SCV catheterization, age >18 years
and informed consent from the patient or his/her next-
of-kin. Exclusion criteria are patient refusal, femoral or
internal jugular catheterization, and impossibility of obtain-
ing good echogenicity.
All operators must have at least three years of experi-
ence with subclavian catheter procedures and must have
completed at least five ultrasound procedures.Randomization
Patients eligible for inclusion are randomized 1:1 in fixed
blocks of 10, without stratification, by a computerized
number generator list provided by a statistician not
involved in the determination of eligibility or in the as-
sessment of outcomes. All assignments are made through
a dedicated, password protected, SSL-encrypted website.
Randomized patients are given a number corresponding
to a «SUBGEUS Number».Study protocol
Patients are randomized to a ‘real-time ultrasound guid-
ance and examination’ method or to a ‘standard’ (landmark
and radiographic) method, with study treatment beginning
within one hour of randomization.
The predefined length of insertion is based on patient
height and calculated as: height/10 - 2 cm for right sub-
clavian vein sites and height/10 + 2 cm for left subclavian
vein sites [9]. Patients are placed in the Trendelenburg
position. The operator will evaluate the likelihood of
difficult cannulation, based on various patients factors,
including obesity (body mass index >30 kg/m2), coagu-
lation disorders, short neck, acute respiratory failure,
agitation, and history of SCV cannulation.
Before starting the procedure, the operating physician
uses maximal sterile-barrier precautions, including a mask,
a cap, a sterile gown and gloves and handwashing.
The various procedure times, T0 to T5, are defined as:
T0: Start of the procedure, defined as when the
physician begins skin disinfection with 2%
chlorhexidine. Large sterile drapes are set. If necessary,
a local anesthetic (1% lidocaine solution) is applied with
a 22-gauge needle. Ultrasound guided determination of
the puncture site is identified in patients randomized to
the ultrasound group.
T1: Skin puncture.
T2: Return of venous blood into the syringe attached to
the needle, followed by correct insertion of the guide
according to Seldinger’s technique. In case of uncorrected
insertion of the guide, a new site is punctured, with T2
defined as the time of return of venous blood from the
new puncture, followed by correct insertion of the guide.
T3: Application of dressing after catheter insertion,
purge and fixation. Lines of perfusion are positioned.
Ultrasound examinations are started or the radiology
technician in the radiology department is contacted.
The chest radiograph device is located in the ICU.
T4: The catheter is checked for placement and
complications. A chest radiograph is taken and
interpreted or the patient has been assessed by
ultrasound examination, depending on randomization.
If there is no evidence of complications or
misplacement, then T4 = T5. If there are complications
or misplacement, corrections are made, including a
chest tube for pneumothorax, and withdrawal or
repositioning if the catheter is misplaced.
T5: End of the procedure, when the catheter is
accurately inserted and controlled.
Complications recorded include arterial puncture, pneu-
mothorax, hemothorax, and misplacement (contralateral
subclavian or jugular route; outside the superior vena cava
or the right atrium).
Patients scheduled for subclavian venous central catheter
Informed consent before catheter cannulation













Procedure times and complications evaluation
(during procedure and until catheter withdrawal or hospital discharge)
Figure 1 CONSORT diagram of the SUBGEUS trial.
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The ipsilateral anterosuperior region of the chest is shaved
if necessary and skin disinfected with 2% chlorhexidine.
If necessary, a local anesthetic (1% lidocaine solution) is
applied. The needle is inserted 1 cm inferior and 1 cm
lateral to the junction of the middle and medial thirds
of the clavicle. Patients for whom cannulation is not
possible with the landmark method will undergo the
procedure under ultrasound guidance on the ipsilateral
side. If highlighted thrombosis occurs, the patient will be
withdrawn from the study and will undergo the procedure
under ultrasound guidance on the contralateral side.
Correct placement of the tip of the catheter after the
procedure is defined as <2.9 cm caudal to the righttracheobronchial angle to avoid intracardiac placement,
as previously described [10].Ultrasound method
The area is prepared (skin disinfection with 2% chlor-
hexidine, local anesthesia with lidocaine 1%) and draped
sterilely as described above. In addition, the ipsilateral
internal jugular and contralateral subclavian areas are
prepared in case of catheter misplacements for proper
ultrasound-guided repositioning. An Envisor or CX-50
ultrasound machine (Philips, Andover, MA, USA) equipped
with a high-resolution 7.5-MHz transducer is used. The
transducer is covered with ultrasonic gel and wrapped in an
Figure 2 Out-of-plane view (short axis) of the needle entering
the subclavian vein with the acoustic shadow in an infraclavicular
approach. N, needle; SCA, subclavian artery; SCV, subclavian vein.
Figure 3 In-plane view (long axis) of guidewire placement
in the subclavian vein using an infraclavicular approach. AV,
axillary vein; GW, guidewire; Rib 1, acoustic shadow on the first rib;
SCV, subclavian vein.
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14 × 147 cm; CIVCO, Kalona, IA, USA).
The ultrasound method applied for SCV catheterization
is a four-step procedure:
1. Preprocedural ultrasound scanning, through an
infraclavicular views, is performed to measure the
depth and caliber of the subclavian vein and to
evaluate its patency. Furthermore, it is used to
identify adjacent structures. The infraclavicular
approach is also chosen for the area of puncture;
if this approach makes evaluation difficult, the
supraclavicular approach will be considered [11].
2. An infraclavicular approaches, as described
previously [7,12-14], is utilized to compare the
ultrasound and landmark methods. Although we use
a high-frequency transducer, which applies tissue
harmonic imaging, depicting two-dimensional views
of the vein is difficult. Physicians use sonoanatomic
landmarks such as the acoustic shadows of the
underlying first thoracic rib and of the sternum to
select an area of interest. The needle is inserted at
the midclavicular line or more laterally, 1 to 3 cm
under the clavicle. Under ultrasound guidance, the
needle is advanced through the area between the
clavicle anteriorly and the first rib posteriorly. The
transducer is maneuvered to depict the subclavian
vein, either the longitudinal (in-plane) or the
transverse (out-of-plane) axis, and to achieve an
optimum plane of catheterization (Figures 2 and 3).
Doppler techniques are also used to confirm the
two-dimensional findings.
3. The needle is advanced slowly, so that its trajectory
and/or tip can be detected superficially, toward the
lumen of the vein on the longitudinal axis, while
being purposefully directed toward the acoustic
shadow of the thoracic rib underneath, thus
minimizing the risk of damaging the pleurae and lung
if transfixion of the vein is inevitable. Therefore, the
needle enters the lumen of the vessel at the level of
the subclavian vein, depending on the angle of
penetration and the depth of the vein from the skin
surface. In addition, the course of the needle is
dependent on adjustments performed by the operator
to visualize its trajectory on the longitudinal axis.
Hence, the angle of penetration and the course of the
needle can be modified in each patient during
catheterization, making this technique largely
operator-dependent. If a supraclavicular approach is
used, the needle is inserted with the probe placed in
the supraclavicular fossa, just lateral to the clavicular
head of the sternocleidomastoid muscle in a long or
short axis. The needle enters the subclavian vein
before its confluence with the internal jugular vein.
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technique; thereafter, the internal jugular veins and
the contralateral subclavian vein are scanned to
identify possible misplacements, allowing the catheter
to be repositioned under ultrasound guidance.
Postprocedural ultrasound examination includes
detection of:
1. Pneumothorax, as determined from lung-sliding,
comet-tail artifacts, lung-point and lung pulse.
Between two ribs (identifiable by their acoustic
shadow), the interface between the thoracic wall
and the lung consists of a hyperechogenic line that
represents both the visceral and parietal pleura.
Lung-sliding is a to-and-fro movement of this
hyperechogenic line, which follows respiratory
movements [15]. Comet-tail artifacts are grossly
vertical artifacts spreading from the hyperechogenic
line to the inferior edge of the screen [16]. The lung
pulse refers to the subtle rhythmic movement of
the visceral upon the parietal pleura with cardiac
oscillations [17]. The lung point refers to the
depiction of the typical pattern of pneumothorax,
which is simply the absence of any sliding or moving
B-lines at a physical location where this pattern
consistently transitions into an area of sliding,
representing the physical limit of pneumothorax
as mapped on the chest wall [18].
An algorithm for diagnosing pneumothorax was
recently proposed, based on the sonographic signs of
pneumothorax [19]:
absence of lung sliding
absence of B-lines
presence of lung point(s)
absence of lung pulse.
2. Hemothorax with absence of pleural effusion at the
pleural dead-end.
3. Misplaced catheters, either at an aberrant or too
distal position. An aberrant position is defined as
catheter-tip visualization: a) in the ipsilateral
internal jugular vein or contralateral subclavian
vein, or b) in the contralateral internal jugular vein.
A too distal position is defined as visualization of the
catheter tip in the intracardiac position - intra-atrial
or intraventricular - or in the inferior vena cava.
4. Postprocedural ultrasound examination also includes
contrast tests: saline transthoracic contrast
echocardiography performed to confirm appropriate
placement consists of injecting 10 ml of normal
saline in a 10-ml syringe and checking the induced
contrast in the right atrium with linear flow coming
from superior vena cava within 2 sec [20,21].Patients in the ultrasound group also undergo a chest
x-ray after the procedure to confirm the absence of
pneumothorax or misplacement.
Study endpoints
The primary endpoint is the procedure time between the
beginning of the procedure (T0) and when the catheter is
controlled (T4).
The secondary outcomes are the procedure times (T0 to
T5) of the two strategies, rates of per procedure complica-
tions (pneumothorax, hemothorax, and misplacement),
failure of the technique and central venous catheter
infection (catheter-related sepsis without bacteremia or
catheter-related bloodstream infections). Catheter-related
sepsis without bacteremia and catheter-related blood-
stream infections are described below:
1. Catheter-related sepsis without bacteremia is defined
according to the combination of 1) fever (body
temperature ≥38.5°C) or hypothermia (body
temperature ≤36.5°C), 2) catheter colonization,
3) regression of fever or hypothermia within the
48 h following catheter removal and with no change
in antimicrobial therapy, or presence of pus at the
catheter insertion site, and 4) no other identified
sources of infection.
2. Catheter-related bloodstream infections are
defined as the combination of 1) fever (body
temperature ≥38.5°C) or hypothermia (body
temperature ≤36.5°C), 2) one or more positive
peripheral blood cultures drawn 48 h before or
after catheter withdrawal, 3) isolation of the same
organism (same species and same susceptibility
pattern) from the colonized catheter or from the
catheter insertion site, or a blood-culture differential
time-to-positivity of 2 h or longer, and 4) no apparent
source of bacteremia other than the catheter. In
patients with positive coagulase negative staphylococci
bacteremia, at least two positive cultures from
separate blood samples are required.
Follow-up
The following variables are collected:
Pre-randomization and during baseline assessment -
gender, age height, weight, cardiac status (hypertension,
cardiac failure, and ischemic heart failure), respiratory
status (history of chronic obstructive pulmonary disease,
asthma status, and long-term home oxygen), smoking
status, alcohol status, history of diabetes mellitus, IGS
2, SOFA, indication for the SCV catheter and blood
parameters (WBC count, hemoglobin, prothrombin time,
fibrinogen, urea, and creatinine).
During the catheter procedure - highlighted throm-
bosis, the various procedure times (T0 to T5), number
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cardiac rhythm during wire insertion, use of the supra- or
infra-clavicular approach, out-of-plane or in-plane ultra-
sound approach, depth of the subclavian vein, difficulty of
subclavian vein visualization (very easy, easy, intermediate,
difficult, or impossible), switch of the puncture site, oper-
ator or randomization group, arterial puncture, absence
of internal jugular or contralateral subclavian placement,
control of contrast test, absence of pneumothorax, and
hemothorax.
After the procedure - duration of catheterization, occur-
rence of catheter infection.
Sample size estimation, protocol drop-out and suspension
Studies have shown that ultrasound can detect the ab-
sence of complications and the correct positioning of the
catheter and can reduce the processing time of the audit
report on chest radiographs [8,22]. The standard deviation
of the processing time varies between 5 min and 25 min.
In this study, 2 × 133 patients are needed to detect a
10 min (standard deviation equals 25 min) difference in
the primary outcome, at a two-sided α level of 0.05 and a
statistical power of 90%. It was estimated that 10% of
patients would cross-over or drop-out, resulting in a total
of 300 patients, 150 in each group. An interim analysis is
planned after enrollment of the first 82 (1/4 of inclusions)
patients to review data relating to patient safety and
quality of trial conduct (software East (Cambridge, MA,
USA, http://www.cytel.com), Kim-DeMets method with
Pocock boundary). The committee monitoring data and
safety will recommend stopping the trial if its continuation
will compromise patient safety, defined as a between-group
difference in serious adverse events.
If ultrasound highlights a thrombosis, the other sub-
clavian vein will be used for cannulation. If cannulation
of the subclavian vein is impossible, the patient will be
excluded from the study and cannulation will be attempted
using the internal jugular or femoral vein. These patients
will be analyzed according to their originally assigned group
on an intention-to-treat (ITT) basis.
Statistical analysis
Statistical analyses will be performed on ITT populations.
Student’s unpaired t-test or the Mann-Whitney test (if
appropriate) will be used for primary outcome analysis.
The Shapiro-Wilk test will be used to assess normality,
and the Fisher-Snedecor test to assess homoscedasticity.
Analysis will be adjusted by random effects linear regres-
sion to 1) take into account adjustments for possibly con-
founding covariates selected according to clinical relevance
(for example, history of venous central catheter procedures,
failure rate of the technique) and 2) consider variations
within and between centers and operators. All effect sizes
will be reported with 95% confidence intervals. Othercontinuous variables will be analyzed identically. Categor-
ical parameters will be compared in the randomized
groups using unadjusted chi-square or Fisher’s exact test.
Analyses will be adjusted using the previously described
adjustment variables in a logistic regression model. If the
frequency of missing data is >5%, an additional analysis
will be performed using the multiple imputation method
(software Stata command [23]). All analyses will be per-
formed using Stata statistical software, release 12 (Stata-
Corp, College Station, TX, USA).
Data handling and record keeping
Data will be handled according to French law. All original
records (including consent forms, CRFs and relevant cor-
respondence) will be archived at the trial site for 15 years.
The clean database file will be made anonymous and
maintained for 15 years.
Study organization
Financial support is provided by a research grant from
the University Hospital of Clermont-Ferrand. The study
is promoted by Clermont-Ferrand University Hospital.
The independent Data and Safety Monitoring Board
(DSMB) ensures that the trial is in accordance with the
Declaration of Helsinki, monitors patient safety and
reviews safety issues as the study progresses. Serious
adverse events and unexpected related or possibly related
serious events are reported blinded to the DSMB within
24 hours and 7 days, respectively.
Discussion
It has become clear that ultrasound approaches have
potential applicability in central venous catheterization.
All previous reports, however, have evaluated parts of the
procedure time during real-time ultrasound guidance
[7]. The times of preparation of the transducer, which
is covered with ultrasonic gel and wrapped in an intra-
operative sterile sheath, and of the ultrasound guidance
itself have not been yet evaluated. These may limit the
findings showing that generalized ultrasound approaches
reduce the time of catheter insertion. The SUBGEUS trial
is the first randomized controlled study to investigate
whether ultrasound real-time guidance and examination
for SCV catheter procedure improves all procedure times.
The primary end-point of the trial is the total procedure
time, from the beginning of procedure until the cath-
eter is controlled. This time may be regarded as being
more representative of the procedure time than the time
between penetration of skin and aspiration of venous
blood into the syringe.
The time to process audit reports on chest radiographs
is reported to be very long, around 80 minutes, and may
depend on the center. In contrast, the time required for
ultrasound examination was much shorter (6.8 ± 3.5 min)
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median processing time was 20 min and ranged from
5 min to 25 min. The device used for chest radiography
is located in our ICU, and the assistant radiologist must
simply be called to take the radiograph with this device.
Potentially, it may be difficult to generalize our results
concerning this part of procedure.
Nevertheless, immediate ultrasound determination of
the absence of misplacement or complications could allow
the very early use of SCV catheters for multidrug perfu-
sion in critically ill patients. The few minutes saved may
represent a potential improvement of vital functions in
the emergency room.
In conclusion, the SUBGEUS trial is an investigator-
initiated pragmatic randomized controlled trial powered
to test the hypothesis that a complete ultrasound approach
(real-time guidance and examination) reduces the proced-
ure time, from the beginning of the procedure to the end of
checking the catheter. The SUBGEUS trial also determines
the impact of the ultrasound approach on most procedure
times and on the occurrence of complications.
Trial status
The trial is ongoing and is actively enrolling patients.
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